Tetanus: Presenter:Walter K Facilitator: DR - Damani
Tetanus: Presenter:Walter K Facilitator: DR - Damani
Tetanus: Presenter:Walter K Facilitator: DR - Damani
PRESENTER:WALTER K
FACILITATOR: DR.DAMANI
OUTLINE
• DEFINITION
• EPIDEMIOLOGY
• AETIOLGY
• PATHOPHYSIOLOGY
• CLINICAL FEATURES
• DIANGOSIS
• MANAGEMENT
• PREVENATION
DEFINITION
TETANUS
• acute onset of hypertonia or
painful muscular contractions (usually of the muscles of the jaw and
neck) and generalized muscle spasms without other apparent medical
cause.
Neonatal
• Defined by the World Health Organization
(WHO) as “an illness occurring in a child who has the normal ability to
suck and cry in the first 2 days of life but who loses this ability between
days 3 and 28 of life and becomes rigid and has spasms.
Maternal tetanus
• is defined by the WHO as tetanus occurring during pregnancy or within 6 weeks after the conclusion of
pregnancy(whether with birth, miscarriage, or abortion).
EPIDEMIOLOG
• Rare in developed countries
• Common in incompletely immunized or unimmunized indivduals
• >60 at high risk;↓ antibodies levels over time
Predisposing factors
• In adequate vaccination
• Wounds:
• Penetrating; stepping on nail, IM injection, tatoo,
• Abrasion
• Dental :extraction,root cannal therapy,
• Devitalized tissue
• Foreign body
• Neonates:
• Infection of the umbilical stump
• Unvaccinated mothers
• Ear piercing
• cirmucission
• Obstetrics: septic abortions
AETIOLOGY
• caused by clostridium tetani;anaerobic gram-positive spore-froming
rod.
• Present in gut of mammals and widely soil
PATHOPHYSIOLOGY
• Inoculation
• Vegetative ;produce exotoxins :1)metalloprotease tetanospasmin; 2)
tetanolysin
• Tetanospasmin:150kD-100kD(heavy chain) &50kD (light Chain)
• 100kD; internalization and uptake
• 50kD; cleaves vesicle associated membrane protein(VAMP)2.(synaptobrevin)
• Retrograde fast axonal transportation
• Translocation
• Inhibition of release of inhibitory neurotransmitters
CLINICAL FEATURES
• Incubation period approx. 8 days but ranges from 3 to 21 days
• Types of types clinically
• Generalized tetanus
• Localized tetanus
• Cephalic tetanus
• Neonatal tetanus
• Generalised tetanus
• Most common
• Localised tetanus
• Unusual form
• involving extremity with contaminated wound
• Excellent prognosis
• Cephalic tetanus
• Uncommon
• 1-2 days
• Poor prognosis
• Usually occurs after head trauma
• Cranial nerve palsies-CN VII
• Neonatal tetanus /tetanus neonatorum
• 3-10 days
• Generalised
• 70% mortality rate
• Irritability
• Poor feeding
• Rigidity
• Facial grimance
• Severe spasms to touch
• Trismus :in ability to open the mouth secondary tomasster muscle
spasms
• Risus sardonicus:grin like posture of hypertonic facial expression
• Opisthotonus; arching of the body with hyperextension
DIAGNOSIS
• History:
• Symptoms: onset, duration,
• Predisposing;
• Examination;
• Neck stiffness
• Posture
• Investigations
DIFFERENTIAL DIAGNOSIS
• Drug induced dystonias
• Trismus due to dental infection
• Strychnine poisoning due to injection of rat poison
MANAGEMENT
Goals of management
1. Halting toxin production
2. Neutralizing unbound toxin
3. Airway management
4. Control of spasms
5. Management of dysautonomia
6. General supportive management
Halting toxin production
• Wound management :
• Debridement; removes spores and necrotic tissue
• Antibiotics therapy
• Metronidazole 500mg IV 6 or 8 hourly
• Penicillin G 2-4u IV 4 or 6 hourly for 7 to 10 days
Neutralizing unbound toxin
• Passive immunization;
• Human tetanus immune globulin(HTIG) 3000-6000units IM (part of dose around the
wound
• Equine antitoxin ;intradermal test 0.1ml(1:10 dilution
• Active immunization
• Different site from that of TIG
Control of spasms
• Diazepam
• 10-30mg IV PRN 1 to 4hourly.max dose 500mg /day
• LORAZEPAM
• Midazolam
• Magnesium sulphate
• Pancuronium
• Baclofen 1000 mega 3 weeks
General supportive management
• Airway management
• Nutrition
PREVENTION
• Vaccination
• Children
• DTaP- at 2,4,6 months
• Mothers
• Males